Go Back
Head of GI Oncology
Reviewing the outcomes in HCC with 1st line immunotherapy
Patients with advanced HCC not eligible for IO in 1st line
Overview of 2nd line treatment options in advanced HCC
Panel Discussion and Summary
Select your medical specialty to receive programmes that matters most to you
The educational programmes hosted on our website are intended for healthcare professionals only.
They are not a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country.
Are you a healthcare professional?